Skills (8)
-
1 Question13 Followers
-
1 Question23 Followers
-
0 Questions14 Followers
-
12 Questions141 Followers
-
243 Questions11599 Followers
Research experience
-
Sep 2011–
presentResearch: nucleic acid-based technologies development
Alacris Theranostics GmbH · R&DGermany · Berlin -
Feb 2011–
Aug 2011Research: nucleic acid-based technologies development
Dahlem Centre for Genome Research and Medical Biology gGmbHGermany · Berlin -
Feb 2008–
Jan 2011Research: SELEX high-throughput development
Max-Planck-Institute for molecular Genetics · Vertebrate Genomics · Nucleic Acid-based TechnologiesGermany · BerlinSELEX, molecular library screening, nucleic acids, in vitro evolution
Other
-
LanguagesGerman, English, basic French, some Spanish
Publications (28) View all
-
Article: Directed evolution of nucleotide-based libraries using lambda exonuclease.
[show abstract] [hide abstract]
ABSTRACT: Directed evolution of nucleotide libraries using recombination or mutagenesis is an important technique for customizing catalytic or biophysical traits of proteins. Conventional directed evolution methods, however, suffer from cumbersome digestion and ligation steps. Here, we describe a simple method to increase nucleotide diversity using single-stranded DNA (ssDNA) as a starting template. An initial PCR amplification using phosphorylated primers with overlapping regions followed by treatment with lambda exonuclease generates ssDNA templates that can then be annealed via the overlap regions. Double-stranded DNA (dsDNA) is then generated through extension with Klenow fragment. To demonstrate the applicability of this methodology for directed evolution of nucleotide libraries, we generated both gene shuffled and regional mutagenesis synthetic antibody libraries with titers of 2×108 and 6×107, respectively. We conclude that our method is an efficient and convenient approach to generate diversity in nucleic acid based libraries, especially recombinant antibody libraries.BioTechniques 12/2012; 53(6):357-64. · 2.67 Impact Factor -
SourceAvailable from: Jörn Glökler
Article: Application of aptamers in therapeutics and for small-molecule detection.
[show abstract] [hide abstract]
ABSTRACT: Nucleic acids that can bind with high affinity and specificity to target molecules are called "apta mers". Aptamers recognise a large variety of different molecule classes. The main focus of this chapter is small molecules as targets. Aptamers are applied complementarily to antibody technologies and can substitute antibodies or small molecules wherever their different properties, such as biochemical nature or highly discriminating capacities, are advantageous. Examples of promising applications of these versatile molecules are discussed in the field of therapeutics and biotechnology with a special view to small-molecule detection.Handbook of experimental pharmacology 02/2006; -
SourceAvailable from: Jörn Glökler
Article: Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications.
[show abstract] [hide abstract]
ABSTRACT: The performance of protein and antibody microarrays is dependent on various factors, one of which is the use of an appropriate microarray surface for the immobilisation of either protein or antibody samples. We have investigated the properties of seven new surfaces in the context of both protein and antibody microarray technology. We have demonstrated the functionality of all new slide coatings and investigated the mean signal to spotted concentration ratio, determined detection limits and calculated coefficients of variation. Moreover, new concepts for slide coatings such as dendrimer and poly(ethylene glycol)-epoxy slides were evaluated and improved qualities of novel slide surfaces were observed. Optimal slide coatings for antibody and protein chips were proposed and the requirements for both technologies were discussed.Journal of Chromatography 09/2003; 1009(1-2):97-104. · 4.53 Impact Factor -
SourceAvailable from: Jörn Glökler
Article: A DNA aptamer with high affinity and specificity for therapeutic anthracyclines.
Aniela Wochner, Marcus Menger, Dagmar Orgel, Birgit Cech, Martina Rimmele, Volker A Erdmann, Jörn Glökler[show abstract] [hide abstract]
ABSTRACT: We describe the characterization of a DNA aptamer that displays high affinity and specificity for the anthracyclines daunomycin and doxorubicin, both of which are frequently used in chemotherapy. Aptamers were isolated from a pool of random sequences using a semiautomated procedure for magnetic beads. All selected aptamers displayed high affinity for the target molecule daunomycin. One aptamer was further characterized and exhibited a dissociation constant (KD) of 20 nM. To examine the aptamer's binding properties and clarify its applicability for diagnostic assays, its performance under various buffer conditions was evaluated. The aptamer proved to be very robust and not dependent on the presence of specific ions. It also tolerated a wide pH range and immobilization via 5'-biotinylation. Furthermore, a competition assay for sensitive daunomycin detection was established. This not only allows the determination of the aptamer's specificity but also allows the quantification of as little as 8.4 microg/L daunomycin and doxorubicin.Analytical Biochemistry 03/2008; 373(1):34-42. · 3.00 Impact Factor -
SourceAvailable from: Jörn Glökler
Article: Semi-automated selection of DNA aptamers using magnetic particle handling.
[show abstract] [hide abstract]
ABSTRACT: We have developed a semi-automatic selection procedure for DNA aptamers. Employing a robotic workstation for magnetic particle handling, this method allows for a fast, reproducible, and parallelized selection of DNA aptamers. The selection protocol is designed to provide high flexibility and versatility in terms of choice of buffers and reagents, as well as stringency of selection. Using this procedure, we have successfully isolated ligand-specific, high-affinity DNA aptamers.BioTechniques 10/2007; 43(3):344, 346, 348 passim. · 2.67 Impact Factor